Variable No EACA (N = 27 EACA (N  = 64)  P
Mean ± SD Median Mean ± SD Median
Age 57.5 ± 8.88 59.1 54.5 ± 9.79 56.1 0.172
Duration (hours) 5.79 ± 1.72 5.62 6.17 ± 1.40 5.93 0.278
Initial Fib 272.9 ± 79.7 276.0 246.2±106.8 220.0 0.229
Post Fib 204.7 ± 68.5 194.0 183.0 ± 54.3 173.0 0.113
Change in Fib 68.2 ± 60.3 77.0 61.3 ± 83.8 51.0 0.661
Initial Creatinine 0.80 ± 0.23 0.80 0.80 ± 0.25 0.75 0.925
Initial Tbili 1.57 ± 1.09 1.40 3.59 ± 4.73 2.55 <0.001
Initial INR 1.37 ± 0.20 1.37 1.45 ± 0.22 1.45 0.085
RBCs 931.0 ± 1176 600.0 1871 ± 2262 1200 0.016
MELD score 8.29 ± 4.16 8.29 11.4 ± 3.38 12.68 <0.001
Categorical Variables n of N=27 % No EACA n of N=64 % EACA P
Sex (% Male) 18 66.7% 42 65.6% 0.924
RBCs 18 66.7% 53 82.8% 0.089
Cell Saver 2 7.41% 7 10.9% 0.720
FFP 14 51.9% 57 89.1% <0.001
Platlets 5 18.5% 32 50.0% 0.006
Factor 7 0 0.00% 2 3.13% 1.000
Liver & Kidney 1 3.70% 1 1.56% 0.508
Retransplant 2 7.41% 3 4.69% 0.631
Thrombus 5 18.5% 6 9.38% 0.292
Mortality 0 0.00% 2 3.13% 1.000
Table 3: Characteristics of the participants with MELD <15 by procedure.